Weiss N S
Natl Cancer Inst Monogr. 1979 Nov(53):139-42.
Despite the incomparability in the reporting of leukemia and lymphoma incidence among populations and the relative rarity of these diseases, real differences in rates are discernible from available data. In general, the incidence of each of the leukemias and lymphomas is lower in Japan than in other Pacific rim populations whose rates are known. Particularly striking is the low incidence of CLL in Japan. Among Japanese in Hawaii, rates of some of these cancers (lymphosarcoma, CML) approach those of whites, whereas rates of other cancers (Hodgkin's disease, multiple myeloma, ALL, CLL, and AML) more closely resemble those of native Japanese. The number of Chinese living in countries served by population-based cancer reporting systems is too small for any firm conclusions to be made about leukemia and lymphoma incidence in this group. The incidence of these diseases in certain other nonwhite Pacific rim residents (i.e., Mexican Americans, blacks, and Maoris) is, by and large, similar to that of whites.
尽管不同人群中白血病和淋巴瘤发病率的报告存在不可比性,且这些疾病相对罕见,但从现有数据中仍可看出发病率的实际差异。总体而言,日本白血病和淋巴瘤的发病率低于其他已知发病率的环太平洋地区人群。日本慢性淋巴细胞白血病(CLL)的低发病率尤为显著。在夏威夷的日本人中,其中一些癌症(淋巴肉瘤、慢性粒细胞白血病)的发病率接近白人,而其他癌症(霍奇金病、多发性骨髓瘤、急性淋巴细胞白血病、慢性淋巴细胞白血病和急性髓细胞白血病)的发病率更接近日本本土人。在有基于人群的癌症报告系统的国家中,华人数量过少,无法就该群体中白血病和淋巴瘤的发病率得出任何确凿结论。在其他一些非白人环太平洋地区居民(即墨西哥裔美国人、黑人、毛利人)中,这些疾病的发病率总体上与白人相似。